All Type of News
When it comes to partnerships among pharmaceutical companies… the distribution industry says “Please, stop”
While strategic partnerships among pharmaceutical companies are currently underway, pharmaceutical distribution companies are sighing with hardship.
The partnerships among pharmaceutical companies have been lasted fo...
What are the similarities among pharmaceutical companies with high revenue of products?
It is shown that pharmaceutical companies with the high number of sales of other companies’ products are more likely to be stingy about investing money on research and development (R&D).
According to the Yakupdotcom(...
Preparation of a follow-up legislation bill for the patent linkage systemInterested by the pharmaceutical industry, a follow-up legislation bill for the patent linkage system is expected to be submitted this October.
On the 7th, Minister Seung Jung,...
|
“Once new employees are hired, they do their shares of work”… Pharm companies are ‘rushing’ for public employment
Pharmaceutical companies are advancing public employment to recruit new employees of the second half of the year.
Recently, companies, such as Dong-A Group, Ahn-Gook Pharm, Green Cross, Chong Kun Dang Pharmaceutical ...
The number of medicines giving incentives for generic substitution is approaching 7700 productsThere are an increasing number of 7700 medicines that gives incentives if generic substitution (preparing same components) is conducted in pharmacies.
Compared to the number of...
|
Hanmi Pharmaceutical challenges invalidity of patent for Ezetrol… A war for exclusive rights has begun
Hanmi Pharmaceutical will challenge nullity of patent for compositions of Merck’s Ezetrol(Ezetimibe), medication for hyperlipidemia.
People’s attention has been drawn to whether the challenge for the nullity would ef...
The distribution industry and GSK made a dramatic agreement for distribution cost
The conflict between the pharmaceutical distribution industry and the Korean corporate of Glaxo Smith Kline (hereinafter referring to GSK) were addressed by a dramatic agreem...
|
On parliamentary inspection, multinational pharmaceutical companies’ witness attended
The number of people who will need to show up for the parliamentary inspection of the administration scheduled on this 7th is going to be significantly reduced.
On the 6th, Congressman Mok-Hee Lee from the New Polit...
The most competitive companies in the pharmaceutical business will compete in the diabetic medicine market
The Korean pharmaceutical companies, such as CJ, Yuhan Corporation, Daewoong Pharm Co., will compete in the diabetic medicine market of SGLT-2 inhibitors.
As Astrazeneca(Forxiga), Boehringer Ingelheim(Jardiance), an...
In regards to the Price Profit Redemption Law, the government’s answer was “We won’t change anything”
It was told that Ministry of Health and Welfare is reviewing opinions for the law amendment to collect unjust profits of pharmaceutical companies. It also postponed giving an immediate answer for the KRPIA’s argument ...
